Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
Despite being a common viral disease, influenza has very negative consequences, causing the death of around half a million people each year. A neuraminidase located on the surface of the virus plays an important role in viral reproduction by contributing to the release of viruses from infected host...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/11/1513 |
id |
doaj-dd495ad664ac4a9686ab4a7c0e7e0675 |
---|---|
record_format |
Article |
spelling |
doaj-dd495ad664ac4a9686ab4a7c0e7e06752020-11-24T23:48:12ZengMDPI AGMolecules1420-30492016-11-012111151310.3390/molecules21111513molecules21111513Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological ActivityPedro Laborda0Su-Yan Wang1Josef Voglmeir2Glycomics and Glycan Bioengineering Research Center, College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, ChinaGlycomics and Glycan Bioengineering Research Center, College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, ChinaGlycomics and Glycan Bioengineering Research Center, College of Food Science and Technology, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, ChinaDespite being a common viral disease, influenza has very negative consequences, causing the death of around half a million people each year. A neuraminidase located on the surface of the virus plays an important role in viral reproduction by contributing to the release of viruses from infected host cells. The treatment of influenza is mainly based on the administration of neuraminidase inhibitors. The neuraminidase inhibitors zanamivir, laninamivir, oseltamivir and peramivir have been commercialized and have been demonstrated to be potent influenza viral neuraminidase inhibitors against most influenza strains. In order to create more potent neuraminidase inhibitors and fight against the surge in resistance resulting from naturally-occurring mutations, these anti-influenza drugs have been used as templates for the development of new neuraminidase inhibitors through structure-activity relationship studies. Here, we review the synthetic routes to these commercial drugs, the modifications which have been performed on these structures and the effects of these modifications on their inhibitory activity.http://www.mdpi.com/1420-3049/21/11/1513influenza treatmentneuraminidase inhibitorsorganic synthesistotal synthesissialic acid analogues |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pedro Laborda Su-Yan Wang Josef Voglmeir |
spellingShingle |
Pedro Laborda Su-Yan Wang Josef Voglmeir Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity Molecules influenza treatment neuraminidase inhibitors organic synthesis total synthesis sialic acid analogues |
author_facet |
Pedro Laborda Su-Yan Wang Josef Voglmeir |
author_sort |
Pedro Laborda |
title |
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity |
title_short |
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity |
title_full |
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity |
title_fullStr |
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity |
title_full_unstemmed |
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity |
title_sort |
influenza neuraminidase inhibitors: synthetic approaches, derivatives and biological activity |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2016-11-01 |
description |
Despite being a common viral disease, influenza has very negative consequences, causing the death of around half a million people each year. A neuraminidase located on the surface of the virus plays an important role in viral reproduction by contributing to the release of viruses from infected host cells. The treatment of influenza is mainly based on the administration of neuraminidase inhibitors. The neuraminidase inhibitors zanamivir, laninamivir, oseltamivir and peramivir have been commercialized and have been demonstrated to be potent influenza viral neuraminidase inhibitors against most influenza strains. In order to create more potent neuraminidase inhibitors and fight against the surge in resistance resulting from naturally-occurring mutations, these anti-influenza drugs have been used as templates for the development of new neuraminidase inhibitors through structure-activity relationship studies. Here, we review the synthetic routes to these commercial drugs, the modifications which have been performed on these structures and the effects of these modifications on their inhibitory activity. |
topic |
influenza treatment neuraminidase inhibitors organic synthesis total synthesis sialic acid analogues |
url |
http://www.mdpi.com/1420-3049/21/11/1513 |
work_keys_str_mv |
AT pedrolaborda influenzaneuraminidaseinhibitorssyntheticapproachesderivativesandbiologicalactivity AT suyanwang influenzaneuraminidaseinhibitorssyntheticapproachesderivativesandbiologicalactivity AT josefvoglmeir influenzaneuraminidaseinhibitorssyntheticapproachesderivativesandbiologicalactivity |
_version_ |
1725486768445194240 |